In The News: Kirk Kerkorian School of Medicine at UNLV
Sunday marked another day of more than 2 million Americans receiving the COVID-19 vaccine. The CDC will soon publish guidelines for people who are fully vaccinated.
Don’t skip that second shot. As Clark County awaits its first shipment of the single-dose COVID-19 vaccine manufactured by the Johnson & Johnson-owned Janssen, more than 300,000 people are halfway through their regimens of previously approved two-shot vaccines — and health officials remind them to stay the course.
Appointment-only COVID-19 vaccinations are available at UNLV.
Over the past few weeks, 8 News now has brought you stories of life-changing events when it comes to heart disease and heart failure. We’re wrapping up our series with eight simple things you can do today to keep your ticker healthy and add years to your life.
Starting any job amid a pandemic can be daunting, but imagine if the position involved leading a new medical school.
In just five years, UNLV has earned full medical school accreditation.
With clinical trials planned or underway, children might be able to start receiving COVID-19 vaccines by this fall.
More Nevadans are becoming eligible for the COVID-19 vaccine, and among the newly-added groups are grocery store employees.
More Nevadans are now eligible to receive the COVID-19 vaccine starting Tuesday, but appointment scheduling hasn’t opened yet at some sites like Cashman Center.
“We are writing to share good news. At its February 2021 meeting, the LCME (Liaison Committee on Medical Education) voted to grant full accreditation to the medical education program of the University of Nevada, Las Vegas School of Medicine.”
“We are writing to share good news. At its February 2021 meeting, the LCME (Liaison Committee on Medical Education) voted to grant full accreditation to the medical education program of the University of Nevada, Las Vegas School of Medicine.”
The Food and Drug Administration issued an emergency use authorization for the Johnson & Johnson vaccine last week, with health experts telling Newsweek that its approval could enable the United States to achieve herd immunity by early summer.